Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoY

Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surging 50%. Robust demand across therapeutic segments, improved capacity utilisation, and traction in regulated markets supported growth. The stock remains in an uptrend despite overbought technical indicators.

Raccontata daeconomictimes.indiatimes.com